Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-001 for advanced pancreatic cancer
CTR20171139Phase 2Active
- Sponsor
- Huashi Tianfu
- Start
- Nov 2017
- Countries
- 1
01
Overview
A Phase 2 trial of K-001 in pancreatic cancer (PC), pancreatic adenocarcinoma (PDAC), sponsored by Huashi Tianfu. Started Nov 2017; status: active.
02
Drugs
K-001
03
Conditions
pancreatic cancer (PC)pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on CTR20171139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171139.